Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4261]

EMCC 2011: New hope for advanced post-menopausal breast cancer patients resistant to hormonal therapy

EMCC 2011: New hope for advanced post-menopausal breast cancer patients resistant to hormonal therapy

EMCC 2011: Zoledronic acid reduces the recurrence of breast cancer in post-menopausal women

EMCC 2011: Zoledronic acid reduces the recurrence of breast cancer in post-menopausal women

EMCC 2011: Aromatase inhibitor letrozole guards against breast cancer relapse for up to eight years

EMCC 2011: Aromatase inhibitor letrozole guards against breast cancer relapse for up to eight years

EMCC 2011: Breast cancer tumour make-up changes through the course of disease; regular biopsies needed to ensure correct treatment

EMCC 2011: Breast cancer tumour make-up changes through the course of disease; regular biopsies needed to ensure...

EMCC 2011: Bone-strengthening drug gives pain relief in prostate cancer bone metastases

EMCC 2011: Bone-strengthening drug gives pain relief in prostate cancer bone metastases

EMCC 2011: Radiotherapy between or during chemotherapy cycles 'reduces risk of breast cancer recurrence'

EMCC 2011: Radiotherapy between or during chemotherapy cycles 'reduces risk of breast cancer recurrence'

EMCC 2011: Phase II study shows new cancer drug combination significantly delays breast cancer progression

EMCC 2011: Phase II study shows new cancer drug combination significantly delays breast cancer progression

FDA approves denosumab for bone loss in hormone-treated breast and prostate cancer

FDA approves denosumab for bone loss in hormone-treated breast and prostate cancer

Skin cancer expert to lead Manchester's Paterson Institute

Skin cancer expert to lead Manchester's Paterson Institute

European Institute of Oncology - Journal highlights of the week

European Institute of Oncology - Journal highlights of the week

More from ecancer